DC

Decheng Capital Portfolio holdings

AUM $661M
1-Year Est. Return 299.97%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+299.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$661M
AUM Growth
-$82.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
19
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

1
+$10.8M
2
+$8.7M
3
+$7.52M
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$4.32M
5
KRYS icon
Krystal Biotech
KRYS
+$2.66M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGON icon
1
CG Oncology
CGON
$5.49B
$431M 65.21%
6,371,669
NUVB icon
2
Nuvation Bio
NUVB
$1.66B
$111M 16.84%
25,954,439
UPB
3
Upstream Bio Inc
UPB
$455M
$24.5M 3.71%
2,724,868
-418,210
ACRS icon
4
Aclaris Therapeutics
ACRS
$635M
$15.2M 2.29%
4,041,736
AARD
5
Aardvark Therapeutics
AARD
$89.7M
$14.8M 2.23%
3,917,299
LYEL icon
6
Lyell Immunopharma
LYEL
$404M
$13.9M 2.1%
692,050
NAMS icon
7
NewAmsterdam Pharma
NAMS
$3.94B
$10.4M 1.57%
325,057
-267,000
RCUS icon
8
Arcus Biosciences
RCUS
$3.19B
$10.3M 1.56%
477,819
-63,740
RVMD icon
9
Revolution Medicines
RVMD
$33.5B
$9.09M 1.38%
93,500
-106,500
EQ icon
10
Equillium
EQ
$183M
$8.89M 1.35%
4,447,308
BYSI icon
11
BeyondSpring
BYSI
$69.1M
$6.23M 0.94%
3,800,702
ZNTL icon
12
Zentalis Pharmaceuticals
ZNTL
$285M
$3.1M 0.47%
1,323,327
KRYS icon
13
Krystal Biotech
KRYS
$9.11B
$1.89M 0.29%
7,300
-10,000
PYXS icon
14
Pyxis Oncology
PYXS
$114M
$477K 0.07%
326,810
AURA icon
15
Aura Biosciences
AURA
$772M
– –
-360,483
CRNX icon
16
Crinetics Pharmaceuticals
CRNX
$3.75B
– –
-92,700
FDMT icon
17
4D Molecular Therapeutics
FDMT
$518M
– –
-44,311
NUVB.WS
18
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
– –
-646,057
RZLT icon
19
Rezolute
RZLT
$318M
– –
-59,900